News | July 06, 2022
Regeneron completes purchase of Sanofi's stake in Libtayo
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
New Director supports NASDAQ rule on diversity
Bayer now present in four of the largest biotechnology hubs in the United States
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications
Subscribe To Our Newsletter & Stay Updated
